Case Report: Late-Onset Mitochondrial Disease Uncovered by Metformin Use in a Patient With Acute Verbal Auditory Agnosia
ConclusionsTo our knowledge, this is the first report of a patient having late-onset MELAS syndrome that manifested as acute verbal auditory agnosia, which was identified after the patient began using metformin. Metformin is known to inhibit mitochondrial function and could trigger clinical features of MELAS syndrome. We encourage clinicians to maintain a high level of awareness that diabetes mellitus can be caused by mitochondrial disease and to exercise caution in the prescription of metformin.
Source: Frontiers in Neurology - Category: Neurology Source Type: research
More News: Acyclovir | Brain | Diabetes | Diabetes Mellitus | Emergency Medicine | Encephalitis | Endocrinology | Fortamet | Headache | Laboratory Medicine | Metformin | Migraine | Mitochondrial Disease | Neurology | Sports Medicine | Stroke | Zovirax